13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950123-23-005049
Total Value
$142.0M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,346,934 | $71.9M | 50.60% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $47.6M | 33.50% |
| 3 | PRIME MEDICINE INC | PRME | 1,835,876 | $22.6M | 15.90% |